Apr 13, 2018 ... Al Haj et al v. Pfizer Inc, No. 1:2017cv06730 - Document 60 (N.D. Ill. 2018) case opinion from the Northern District of Illinois US Federal District ...
Jan 19, 2018 ... Rodney Guilbeau v. Pfizer Inc., No. 17-2056 (7th Cir. 2018) case opinion from the US Court of Appeals for the Seventh Circuit.
Parties, docket activity and news coverage of federal case American Sales Company, LLC v. Pfizer, Inc. et al, case number 2:14-cv-00361, from Virginia Eastern ...
Apr 12, 2017 ... The case is United States of America et al. ex rel. Catherine A. Brown et al. c. Pfizer Inc., case number 2:05-cv-06795 in the U.S. District Court ...
Court of Appeal, First District, Division 2, California. James CLAYWORTH, et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Defendants and Respondents.
Ilenia Migliaccio,; Luca Malorni,; Christopher D Hart,; Cristina Guarducci and; Angelo Di LeoEmail author ... Migliaccio et al.; licensee BioMed Central. 2015.
Of these, 5.8% switched, 51.3% permanently discontinued all anticholinergic agents, and .... Detrol, Detrol LA and Toviaz (Pfizer Inc., New York, New York). ‡ .... switches are almost one third the rate observed by D'Souza et al (5.8% vs 13 %). ... Ms. Migliaccio-Walle led the manuscript preparation, provided oversight and ...
Mar 10, 2016 ... postmenopausal patients with all stages of ER ю breast cancer (1). ...... Luca Malorni, Mario Giuliano, Ilenia Migliaccio, et al. Resistance.
However, not all patients have a durable response with single endocrine agents, and ... The OncotypeDx recurrence score (Genomic Health Inc) is clinically ..... L. Malorni is a consultant/advisory board member for Pfizer and provided expert ..... Rossi S,; Basso M,; Strippoli A,; Dadduzio V,; Cerchiaro E,; Barile R,; et al.